25.8 C
Sunday, June 16, 2024
Home Cancer Immunotherapy

Cancer Immunotherapy

Michael Schneider, MD, PhD

Home » Michael Schneider, MD, PhD Researcher Spotlight: Michael Schneider, MD, PhD THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA Treatment of lymphoma has been revolutionized by the development of chimeric antigen receptor (CAR) T-cell therapies, which elicit robust responses in many patients. However, a large number of patients still relapse after CAR T cell therapy, and Dr....

Tomohiro Aoki, MD, PhD

Home » Tomohiro Aoki, MD, PhD Researcher Spotlight: Tomohiro Aoki, MD, PhD UNIVERSITY HEALTH NETWORK Peykoff Initiative Investigator Cancer cells exist within a greater tumor microenvironment that is modified by tumor cells to support their growth and proliferation. These cells can also modify their environment to help avoid immune detection, thereby supporting continued survival within the body. “Our...

Surviving Hematology/Oncology Fellowship and Beyond: A Twitter Discussion With Current Fellows and Fellowship Aspirants

By Aqsa Mumtaz, MD, Gliceida Galarza, MD, Houssein Safa, MD, Humaira Sarfraz, MD, Saurabh Zanwar, MD, Muhammad Salman Faisal, MD, Fernando Diaz, MD, Pamela Contreras-Chavez, MD, Ghulam R. Mohyuddin, MD, and Karun Neupane, MD To address the common questions that aspiring fellows and current fellows have about hematology/oncology fellowship, HemOncFellows’ Network (@HemOncFellows) organized two...

Changing The Narrative: 10 Recommendations for Caring for Young Adults With Lung Cancer

By Narjust Florez, MD, Fatima Wilder, MD, MSc, Lauren Kiel, BS, and Rebekah Kaufman, MSIt is about time that we change the narrative of lung cancer being a disease that impacts elderly men with a smoking history into one that encompasses our modern reality of an inclusive patient population, including women and especially including...

Erin Parry, MD, PhD

Researcher Spotlight Home » Erin Parry, MD, PhD Researcher Spotlight: Erin Parry, MD, PhD DANA-FARBER CANCER INSTITUTE Dr. Parry’s research is centered at the intersection of genomics and cancer immunotherapy, with a focus on B cell lymphomas. Her LRF research project is aimed at understanding...

Crisis in Clinical Research: Solutions from the AP Perspective

Crisis in Clinical Research: Solutions from the AP Perspective Thursday, August 17, 2023   (0 Comments) Posted by: Jennifer Ginest Just released, the JADPRO Executive Summary of Crisis in Clinical Research: Solutions from the AP Perspective, a panel discussion at the JADPRO Workshop 2023 Meeting. Presented in collaboration with the Advanced Practitioner Society for Hematology...

Advanced Practice Providers (APPs) Are Essential to Continuity of Cancer Care, Especially in Rural Communities

By Whitney Pritham, APRN, CNPI walked into the exam room to meet with my next patient. “So, are you leaving?” he asked as I came through the door. “Well, no,” I responded. “Why?” “My next three appointments are with a different nurse practitioner. Since I wasn’t scheduled with you, I thought you may be leaving. Can...

Celebrating the 18th Annual Best of ASCO in Beirut

It was such a great pleasure and satisfaction to organize and hold the 18th Annual Best of ASCO (BOA) Lebanon Meeting on July 7-8, 2023, at the American University of Beirut Medical Center (AUBMC) in a hybrid format from the Daniel ACC Building Ground Floor Conference Rooms. Speakers and attendees in Lebanon were present...

Everything You Need to Know About Hematology-Oncology Fellowship Applications: Tips From Current and Incoming Fellows

By Karun Neupane, MD, Muhammad Salman Faisal, MD, Zunairah Shah, MD, Mercy C. Anyanwu, MD, Sushmita Khadka, MD, Laercio DaSilva, MD, Pamela Contreras-Chavez, MD, Andrea Anampa-Guzmán, MD, and Aakash Desai, MD, MPHTo address the common questions that fellowship applicants have, especially those applying for a hematology-oncology fellowship, HemOncFellows Network (@HemOncFellows) organized a Twitter Spaces session...

Hematology/Oncology Training Must Evolve Now to Meet the Workforce Challenges of the Future: A Fellow’s Perspective

By Matthew Kurian, MDFrom chemotherapy and immunotherapy to targeted treatments, hematology/oncology is exploding with new and exciting developments each day. If one does not enjoy consistently learning, changing, and adapting, then this field will become a difficult one to keep up with. To become a good hematologist and oncologist, one needs to develop the...

Time Management Tips


clear sky
25.8 ° C
27 °
22.5 °
55 %
1 %
31 °
34 °
34 °
34 °
30 °

Must Read